• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丙戊酰辅酶A代谢产物的合成及线粒体内水平。

Synthesis and intramitochondrial levels of valproyl-coenzyme A metabolites.

作者信息

Silva M F, Ruiter J P, IJlst L, Allers P, ten Brink H J, Jakobs C, Duran M, Tavares de Almeida I, Wanders R J

机构信息

Department of Clinical Chemistry and Paediatrics, University of Amsterdam, The Netherlands.

出版信息

Anal Biochem. 2001 Mar 1;290(1):60-7. doi: 10.1006/abio.2000.4947.

DOI:10.1006/abio.2000.4947
PMID:11180937
Abstract

A number of valproate adverse reactions are due to its interference with several metabolic pathways, including that of fatty acid oxidation. In order to resolve which mitochondrial enzymes of fatty acid oxidation are inhibited by which VPA intermediates we have developed methods to synthesize their CoA ester forms. This paper describes the synthesis of VPA acyl-CoA ester metabolites as well as data on the fate of VPA in rat liver mitochondria. Valproyl-CoA, Delta2-valproyl-CoA, and 3-OH-valproyl-CoA were obtained through chemical synthesis. 3-Keto-valproyl-CoA was prepared by a novel enzymatic procedure followed by a combination of solid-phase extraction and preparative HPLC purification. This approach proved to be efficient in obtaining all the beta-oxidation intermediates of valproyl-CoA. The synthetic standards were used for the determination of intramitochondrial concentrations of valproyl-CoA, Delta2-valproyl-CoA, 3-OH-valproyl-CoA, and 3-keto-valproyl-CoA by HPLC. These levels were determined after incubation of intact rat liver mitochondria with VPA under conditions of state 3 and state 4 respiration. The results show that valproyl-CoA and to a much lesser extent 3-keto-valproyl-CoA are the main metabolites of VPA in mitochondria. This information will be of great use in resolving the mechanisms involved in the inhibition of mitochondrial processes like fatty acid oxidation by VPA.

摘要

丙戊酸盐的许多不良反应是由于其干扰了包括脂肪酸氧化在内的多种代谢途径。为了确定脂肪酸氧化的哪些线粒体酶被哪些丙戊酸(VPA)中间体所抑制,我们开发了合成其辅酶A酯形式的方法。本文描述了VPA酰基辅酶A酯代谢物的合成以及VPA在大鼠肝线粒体中的代谢数据。通过化学合成获得了丙戊酰辅酶A、Δ2-丙戊酰辅酶A和3-羟基丙戊酰辅酶A。3-酮基丙戊酰辅酶A通过一种新的酶促方法制备,随后结合固相萃取和制备型高效液相色谱(HPLC)纯化。该方法被证明在获得丙戊酰辅酶A的所有β-氧化中间体方面是有效的。合成标准品用于通过HPLC测定线粒体内丙戊酰辅酶A、Δ2-丙戊酰辅酶A、3-羟基丙戊酰辅酶A和3-酮基丙戊酰辅酶A的浓度。这些水平是在完整的大鼠肝线粒体与VPA在状态3和状态4呼吸条件下孵育后测定的。结果表明,丙戊酰辅酶A以及程度小得多的3-酮基丙戊酰辅酶A是VPA在线粒体中的主要代谢物。这些信息对于解析VPA抑制线粒体过程(如脂肪酸氧化)所涉及的机制将非常有用。

相似文献

1
Synthesis and intramitochondrial levels of valproyl-coenzyme A metabolites.丙戊酰辅酶A代谢产物的合成及线粒体内水平。
Anal Biochem. 2001 Mar 1;290(1):60-7. doi: 10.1006/abio.2000.4947.
2
Valproyl-dephosphoCoA: a novel metabolite of valproate formed in vitro in rat liver mitochondria.丙戊酰去磷酸辅酶A:一种在大鼠肝线粒体中体外形成的丙戊酸盐新型代谢产物。
Drug Metab Dispos. 2004 Nov;32(11):1304-10. doi: 10.1124/dmd....
3
Studies on the extra-mitochondrial CoA -ester formation of valproic and Delta4 -valproic acids.丙戊酸和Δ4-丙戊酸的线粒体外辅酶A酯形成的研究。
Biochim Biophys Acta. 2007 Apr;1771(4):533-43. doi: 10.1016/j.bbalip.2007.01.010. Epub 2007 Jan 23.
4
Effect of alpha-fluorination of valproic acid on valproyl-S-acyl-CoA formation in vivo in rats.
Drug Metab Dispos. 2001 Sep;29(9):1210-5.
5
Pyruvate uptake is inhibited by valproic acid and metabolites in mitochondrial membranes.丙酮酸摄取在线粒体内膜中受到丙戊酸及其代谢产物的抑制。
FEBS Lett. 2008 Oct 15;582(23-24):3359-66. doi: 10.1016/j.febslet.2008.08.028. Epub 2008 Sep 5.
6
Complete beta-oxidation of valproate: cleavage of 3-oxovalproyl-CoA by a mitochondrial 3-oxoacyl-CoA thiolase.丙戊酸的完全β-氧化:线粒体3-氧代酰基辅酶A硫解酶对3-氧代戊酰辅酶A的裂解。
Biochem J. 2002 Mar 15;362(Pt 3):755-60. doi: 10.1042/0264-6021:3620755.
7
New insights on the mechanisms of valproate-induced hyperammonemia: inhibition of hepatic N-acetylglutamate synthase activity by valproyl-CoA.关于丙戊酸诱导的高血氨症机制的新见解:丙戊酰辅酶 A 抑制肝 N-乙酰谷氨酸合酶活性。
J Hepatol. 2011 Aug;55(2):426-34. doi: 10.1016/j.jhep.2010.11.031. Epub 2010 Dec 13.
8
Valproic acid utilizes the isoleucine breakdown pathway for its complete β-oxidation.丙戊酸利用异亮氨酸分解途径进行完全β氧化。
Biochem Pharmacol. 2011 Dec 1;82(11):1740-6. doi: 10.1016/j.bcp.2011.07.103. Epub 2011 Aug 6.
9
Effects of valproic acid on cardiac metabolism.丙戊酸对心脏代谢的影响。
Can J Physiol Pharmacol. 2004 Oct;82(10):927-33. doi: 10.1139/y04-096.
10
Isolation and quantitation of long-chain acyl-coenzyme A esters in brain tissue by solid-phase extraction.通过固相萃取法分离和定量脑组织中的长链酰基辅酶A酯。
Anal Biochem. 1994 Aug 1;220(2):321-3. doi: 10.1006/abio.1994.1344.

引用本文的文献

1
Micropatterned primary hepatocyte co-culture (HEPATOPAC) for fatty liver disease modeling and drug screening.用于脂肪性肝病建模和药物筛选的微图案化原代肝细胞共培养(HEPATOPAC)。
Sci Rep. 2023 Sep 22;13(1):15837. doi: 10.1038/s41598-023-42785-9.
2
Relief of CoA sequestration and restoration of mitochondrial function in a mouse model of propionic acidemia.CoA 隔离缓解和线粒体功能恢复在丙酸血症小鼠模型中的作用。
J Inherit Metab Dis. 2023 Jan;46(1):28-42. doi: 10.1002/jimd.12570. Epub 2022 Nov 3.
3
Mitochondria as the Target of Hepatotoxicity and Drug-Induced Liver Injury: Molecular Mechanisms and Detection Methods.
线粒体作为肝毒性和药物性肝损伤的靶点:分子机制和检测方法。
Int J Mol Sci. 2022 Mar 18;23(6):3315. doi: 10.3390/ijms23063315.
4
Dihydrolipoamide dehydrogenase, pyruvate oxidation, and acetylation-dependent mechanisms intersecting drug iatrogenesis.二氢硫辛酰胺脱氢酶、丙酮酸氧化和乙酰化依赖的机制在药物医源性疾病中相互交叉。
Cell Mol Life Sci. 2021 Dec;78(23):7451-7468. doi: 10.1007/s00018-021-03996-3. Epub 2021 Oct 31.
5
Pantothenate kinase activation relieves coenzyme A sequestration and improves mitochondrial function in mice with propionic acidemia.泛酸激酶激活可缓解丙酸血症小鼠辅酶 A 的蓄积并改善线粒体功能。
Sci Transl Med. 2021 Sep 15;13(611):eabf5965. doi: 10.1126/scitranslmed.abf5965.
6
Microphysiological flux balance platform unravels the dynamics of drug induced steatosis.微生理通量平衡平台揭示了药物诱导脂肪变性的动态变化。
Lab Chip. 2018 Aug 21;18(17):2510-2522. doi: 10.1039/c8lc00357b.
7
Mitochondrial Liver Toxicity of Valproic Acid and Its Acid Derivatives Is Related to Inhibition of α-Lipoamide Dehydrogenase.丙戊酸及其酸衍生物的线粒体肝毒性与其对 α- 硫辛酰胺脱氢酶的抑制作用有关。
Int J Mol Sci. 2017 Sep 6;18(9):1912. doi: 10.3390/ijms18091912.
8
Valproic Acid and Hepatic Steatosis: A Possible Link? About a Case Report.丙戊酸与肝脂肪变性:一种可能的关联?关于一例病例报告
Psychopharmacol Bull. 2016 Aug 15;46(2):59-62.
9
Drug Induced Steatohepatitis: An Uncommon Culprit of a Common Disease.药物性脂肪性肝炎:一种常见疾病的罕见病因
Biomed Res Int. 2015;2015:168905. doi: 10.1155/2015/168905. Epub 2015 Jul 26.
10
Valproyl-CoA inhibits the activity of ATP- and GTP-dependent succinate:CoA ligases.丙戊酰辅酶A抑制ATP和GTP依赖性琥珀酸辅酶A连接酶的活性。
J Inherit Metab Dis. 2014 May;37(3):353-7. doi: 10.1007/s10545-013-9657-4. Epub 2013 Oct 24.